ABCLAbCellera Biologics Inc.同业对比
AbCellera Biologics Inc. 与Pharmaceutical Preparations的逐项对比:市值、估值、增长、盈利能力、质量与总回报,以及在同业组内的排名。所有数值均由引擎从 SEC 申报与延迟行情计算,排名仅为组内排序位置 —— 描述性数据,非投资建议。
完整同业对比
同业组:同 SIC 行业分类 (Pharmaceutical Preparations)| 公司 | 市值 | 市盈率(TTM) | 市净率 | 市销率 | 营收同比增长 | 净利同比增长 | 息税前利润率 | 净资产收益率 | 投入资本回报率 | 皮氏 F 值 | 一年总回报 | 股息率 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ABCL本股 | $3.9B#8 | — | 4.4x#6 | 52.0x#5 | 160.6%#2 | 10.1%#7 | -289.0%#6 | -16.3%#11 | -28.0%#4 | — | 179.3%#4 | — |
| XENE | $5.6B#1 | — | 4.5x#7 | 740.8x#8 | — | -47.6%#12 | -4974.3%#8 | -27.8%#12 | -32.5%#5 | — | 56.4%#9 | — |
| ERAS | $5.3B#2 | — | 14.7x#15 | — | — | 23.0%#5 | — | -34.4%#13 | — | — | 814.7%#1 | — |
| EWTX | $5.0B#3 | — | 11.1x#13 | — | — | -25.4%#10 | — | -0.0%#5 | -50.9%#6 | — | 228.9%#2 | — |
| PBLS | $4.9B#4 | — | 4.7x#8 | — | — | — | — | 0.0%#3 | — | — | — | — |
| ACAD | $4.7B#5 | 12.3x#1 | 3.6x#3 | 4.4x#2 | 11.9%#5 | 73.0%#2 | 9.8%#2 | 29.9%#1 | 11.4%#1 | — | 13.2%#14 | — |
| MANE | $4.5B#6 | — | 5.5x#10 | — | — | -164.3%#14 | — | -8.6%#7 | — | — | — | — |
| TNGX | $4.0B#7 | — | 3.9x#4 | 64.3x#6 | 48.3%#4 | 22.0%#6 | -178.4%#5 | -9.9%#9 | — | — | 212.2%#3 | — |
| IDYA | $3.7B#9 | — | 3.1x#1 | 17.1x#4 | 3024.4%#1 | 58.6%#3 | -72.8%#4 | -9.5%#8 | — | — | 58.6%#8 | — |
| AMLX | $3.7B#10 | — | 15.4x#16 | — | -100.0%#8 | 52.0%#4 | — | -60.5%#14 | — | — | 159.9%#6 | — |
| ELVN | $3.6B#11 | — | 4.1x#5 | — | — | -16.5%#8 | — | -11.6%#10 | — | — | 161.5%#5 | — |
| OGN | $3.6B#12 | 17.5x#2 | 3.6x#2 | 0.6x#1 | -2.9%#6 | -78.4%#13 | 14.9%#1 | 18.6%#2 | 4.9%#2 | 5#1 | 34.2%#12 | 2.4%#1 |
| VKTX | $3.4B#13 | — | 8.4x#12 | — | — | -227.1%#15 | — | -88.1%#16 | — | — | 27.1%#13 | — |
| DYN | $3.3B#14 | — | 4.7x#9 | — | — | -40.6%#11 | — | -0.0%#4 | -1301.5%#8 | — | 34.4%#11 | — |
| RCUS | $3.2B#15 | — | 7.0x#11 | 98.4x#7 | -35.3%#7 | -24.7%#9 | -1169.7%#7 | -76.1%#15 | -93.0%#7 | — | 112.0%#7 | — |
| ARQT | $3.2B#16 | 115.2x#3 | 14.4x#14 | 8.5x#3 | 91.3%#3 | 88.5%#1 | -3.3%#3 | -7.3%#6 | -4.1%#3 | — | 47.8%#10 | — |
数值来自 SEC 申报与延迟行情;排名仅为该组内的排序位置 —— 描述性数据,不构成评级或建议。 数据构建于 2026-09-17。
数据来自 SEC XBRL 申报与延迟行情 · 排名为组内排序 · 仅供参考 · 非投资建议